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During 2012, 30 herbal doctors in Belize, Central America, each viewed 50 plant 
specimens with reported medicinal value. Each participant was asked to provide a plant name 
and a medicinal use to identify species used to treat women’s and children’s health issues. 
Chi-square tests indicated that knowing a name and knowing a use were associated (p < 
0.05). Participant gender was not independent of knowing a name or a use. The age of a 
participant was not independent of knowing a name but was independent of knowing a use. 
The district of residence was independent of knowing either name or use. Based on model 
selection by Akaike information criterion, gender was the best fit model for knowing a plant 
name. For use, gender, district, and the null model (participant only) had equal goodness of 
fit. Reports of use were partitioned into 23 usage categories. Six categories had high 
informant consensus (>0.65).  From the categories with high consensus, five species had 
been previously reported for similar uses in relevant studies. 
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Ethnobotany, the scientific study of ethnic groups and their cultural use of plants, 
includes food, construction, and the focus of this study, medicine. Globally, three billion 
people rely on traditional medicine and use plant products for primary health care (Balick 
1999). Although ethnobotanical medicines have sustained many cultures for generations and 
contributed much to the lives of indigenous people, it is studied less frequently by subsequent 
generations (Montenegro and Stephens 2006) and knowledge accumulated over thousands of 
years is at risk of being lost. Medicinal use of plants is not only an important part of culture 
(Ankli et al. 1999) but often traditional medicines are the only accessible or affordable 
healthcare option in developing countries (Balick et al. 1990). Half of the 250,000 flowering 
plants reported are located in the tropics and, of these, only 1% has been investigated for 
their pharmaceutical properties (Jachak and Saklani 2007, Maridass 2010). Tropical 
environments are being deforested at an alarming rate and there is an urgency to gather 
knowledge on the diversity of these habitats before they are destroyed (Amiguet et al. 2005, 
Ankli et al. 1999). Of particular concern is the loss of tropical species that have medicinal 
value (Balick 1999). 
Belize 
 Belize is a relatively small country, approximately the size of Massachusetts with a 
land mass of 22,806 km2, bordered by the Caribbean Sea, Guatemala and Mexico (CIA 
2013). Belize provides an ideal site for investigating medicinal plants. The people have a 
strong ethnobotanical culture and tropical habitats remain. For example, Belize is 80% 
forested versus only 2% for El Salvador, a similar size country (Amiguet et al. 2005).  
Economic Botany  
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For these reasons, Belize was chosen as the site for the investigation presented here. 
Review of Literature 
The first published studies on the Yucatan area, Thompson (1930) and Roys (1931), 
focused on ethnological knowledge and general plant use. In more recent years Pendergast 
(1972), Arnason et al. (1980) have contributed to the acquisition, validation, and 
dissemination of the medicinal plant knowledge of the area. Much of the recent literature 
about medicinal plants in Belize has focused on the Q’eqchi’ Maya subgroup because they 
are culturally less assimilated than other groups (Amiguet et al. 2005). The Q’eqchi’ studies 
used male participants. Female healers, midwives, and women’s and children’s health 
(WCH) issues have not been a strong focus in Belize although this type of study has been 
conducted in the neighboring countries of Mexico (Locklear et al. 2008) and Guatemala 
(Michel et al. 2007). Studies in Belize that did address WCH conditions, such as lead 
exposure in children (Charalambous et al. 2009), or perceptions towards human 
immunodeficiency virus in brothels (Ragsdale et al. 2007), made no mention of traditional 
plant use in the treatment of these or other illnesses. 
Thesis Statement 
The study had five primary objectives: 1) identify plants used in Belize for women 
and children’s health and their use; 2) determine the degree of consensus for medicinal plant 
uses by participating practitioners; 3) identify the plant families most frequently used by the 
practitioners; 4) describe the variation among practitioners in knowing plant name and use 
based on three demographic variables (age, gender, district of residence); 5) Determine 




METHODS AND MATERIALS 
Overview 
 The project began with an extensive literature investigation to determine an area in 
need of study leading to the question: what medicinal plants are used for Belizean women’s 
and children’s health issues and for what ailments are they useful. Information on this subject 
was scarce. Ethnobotany: A Methods Manual (Martin 2004) was helpful in understanding 
some important aspects of ethnobotanical studies including what types of data to collect, how 
they might be used and the value of including a broad range of participants. 
 After completion of the required National Institute of Health on-line training for 
research projects using human subjects, the interview protocol was developed. During this 
time, questionnaires for the personal interviews and for the interviews regarding the name 
and use of medicinal plant specimens were developed. Three Belizeans with experience in 
traditional medicine agreed to participant in the pilot study to test the procedures and 
questionnaires for the project. The pilot study resulted in the revision of several questions 
using terminology more appropriate to the Belizean culture. It also identified the need to 
interview participants in the participant’s native language, usually Spanish. Participants who 
spoke English as a second language gave much more thorough answers when interviewed in 
their native language. These three people were not re-interviewed later nor were their data 
included in this study beyond its use in the assessment of the project protocols during the 
pilot study; however, all later assisted in the project. Heriberto Cocom, a medicinal herbalist 
teacher of plant medicine with more than 60 years of experience and training, provided 
assistance as a liaison to healers and as the project’s plant expert. Virgilio Garcia helped with 
transportation to sites and collected plant voucher specimens used to validate the study. 
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Matilde Garcia also assisted in collecting plant specimens and conducted interviews in 
Spanish for Spanish speaking participants. 
Approvals and Permits 
The National Institutes of Health online training for research involving human 
subjects was completed (certificate number 1228490759) in preparation for this study. The 
Angelo State University (ASU) Institutional Review Board (IRB) approved the project and 
interview methods. Landowner consent forms for plant collection were completed and 
permissions obtained from participating landowners. Plant collecting permits were obtained 
from the government of Belize (Minister of Natural Resources, Ref # CD/60/3/12 (38), May 
2012). 
Study Site 
This study was conducted in the Orange Walk and Cayo Districts of Belize. These 
two adjoining districts are on the western side of the country, both bordering Guatemala. 
Orange Walk shares its northern border with Mexico. Cayo, the southern of the two areas, 
has low mountains and the climate is categorized as tropical monsoon (Am) by the Köppen-
Geiger climate classification system. The Orange Walk District is partially Am in the 
southern portion while the northern area is categorized as tropical wet and dry (Aw) and is 
characterized by low lands and savannahs (Belize Meteorological Service 2013). 
Participant Questionnaires 
Balick (1996) demonstrated the value of interviews in the investigation of local plant 
use when new uses were described after interviewing as many as 40 people. Two forms were 
used during interviews, a personal form and a plant species form. The personal interview 
form, a semi-structured questionnaire consisting of 34 questions, was used to obtain 
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information concerning each participant’s training and background. Questions used were 
similar to those used in interviews by Bussmann and Glenn (2010) and Hilgert and Gil 
(2007). In addition, a plant species form was used to record the names and uses for each plant 
specimen as participants viewed 50 dried and pressed specimens. 
Participants were first asked to fill out and sign a “subject consent to participate in 
research” form. This form was approved by the ASU IRB and was provided to participants in 
both English and Spanish. This form included an explanation of the purpose of the study, 
what participants could expect to occur, and how they could stop participating in the study. 
Participant interviews began with a series of questions to provide a general understanding of 
their background and extent of medicinal knowledge. Interview questions included basic 
information such as name, date of birth, place of birth, age, gender, ethnicity, occupation, 
religion, marital status, and number of people/generations living in their home. Additionally, 
participants were asked their level of education, language ability (fluency, number of 
languages), literacy, who taught them plant medicines, number of years of training, why they 
learned, who they treat, whether or not they charge for services, work with a partner, and 
have or were presently teaching this knowledge to another and, if so, are they related to the 
person being taught. Lastly, they were asked if they maintain a written record of their 
knowledge, how many medicinal species they know, how many recipes for medicine they 
know, and how many species they cultivate for their own use. 
Interviews were conducted in either English or Spanish as requested by the 
participant. A video recording, using a Sony HDR-XR520v Handycam, was used to capture 
aspects of the interviews that do not translate easily to a written form such as a participant’s 
demeanor, and information said in passing. The video data also allowed later review of 
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interviews to verify details when necessary to ensure an accurate dataset. Participants wore a 
wireless microphone to ensure no dialogue was lost. 
Participants 
The 30 participants varied by location of residence, gender, and age. One half (50%) 
of the participants were from the Orange Walk District; the remaining participants were from 
the Cayo District. Males accounted for 40% of the participants; 60% were females. 
Participant ages ranged from 18 to 81 with a mean age of 62. When using Jenks natural 
breaks, participant ages were distributed bimodally with a single outlier on the low end. This 
grouping did not represent the participants well and was not informative. Dividing the 
participants into too many groups would reduce sample size and statistical power of tests. 
Therefore, participants were divided into four groups by age and, in general, the groups 
represented typical stages of progression through life. For example, groups represented 
youths without children, developing family, developed family, and elders. Group 1 consisted 
of one participant who was less than 25 years of age. Group 2 was formed of participants 
whose ages ranged from 25 to 49 and represented 23% of the study group. Group 3 had 
participants from ages 50 to 74 (53%). Group 4 represented 20% of the participants who 
were age 75 and older. These groups were best suited to the data and best represented the 
different life stages of the participants. 
Selection of Plants Used for Women’s and Children’s Health Issues 
During the personal interview, participants were asked to discuss plants of medicinal 
value used for women’s and children’s health issues. Eight of the 30 participants contributed 
a total of 25 species. Heriberto Cocom, the project’s medicinal plant expert, provided an 
additional 25 specimens. These 50 plant specimens comprised the plant set for the plant 
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species interviews. Three species from the 25 selected by the participants, were duplicated in 
the set contributed by the study’s plant expert. This was done as a reliability check for 
participant responses. Responses given for the three duplicate specimens were not included 
in any of the statistical analyses. 
After personal interviews were completed for all participants, a second interview was 
conducted for each participant using the 50 medicinal plant specimens in the study set. Each 
participant viewed the complete set of plants one specimen at a time and was given unlimited 
time to view, smell, and touch the specimen. Often crushing a leaf releases odors in newly 
dried materials so destructive sampling was allowed. All 30 participants completed the set of 
50 specimens. Plant species interviews resulted in a completed data form detailing which 
study plants were known by the participant, the local name of the plant, ailments it was used 
for, and a video recording of the interview. 
Plant Vouchers and Collections 
Each plant species in this study was photographed in its habitat, using a Sony DSC-
H20 10.0 megapixel camera, to preserve details like color, growth form, and habitat. Global 
Positioning System coordinates were recorded for each plant collection area using a Garmin 
unit model M60 (WGS84) with an accuracy of <15m.  Four complete sets of voucher 
specimens were collected, dried, fumigated and received phytosanitary certification from the 
government of Belize. Specimen identifications were accomplished using taxonomic family 
keys at the University of Texas at Austin’s (UTA) Plant Resource Center, comparisons with 
herbaria specimens at the UTA Plant Resource Center, and assistance from botanists Drs. 
Tom Wendt, curator of UTA Plant Resource Center and Billie Turner, Director Emeritus of 
the Plant Resource Center. 
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The data collected in this study are stored in duplicate sets. One is stored by the 
principle investigator, and a second is stored in the Angelo State Natural History Collections 
Herbarium in the Biology Department of ASU. The two sets of records are identical except 
for the original hand written field notes that are retained by the principle investigator. A 
scanned digital copy of these notes are included as part of the second dataset. Reports of this 
study and other end products have been provided to and are archived by the government of 
Belize. 
Four sets of voucher specimens of the 50 medicinal plants used during the plants 
species interviews were collected. A set was donated to The National Herbarium in 
Belmopan, Belize, the Angelo State Natural History Collections Herbarium, and the 
University of Texas at Austin Plant Resource Center. The principle investigator kept the 
fourth set. During the study, no trails were cleared and impact to the land was limited to 
collection of selected specimens as approved by the Forestry Department of Belize. No 
marking, chemical use or transplanting was done. In many cases only a portion of the plant 
was harvested to mitigate long-term harm to the plant. 
Specimens were collected in August, 2012. Plants were pressed using newspapers and 
aluminum ventilators inside standard plant presses coated in polyurethane. A simple drying 
cabinet approximately 20” x 20” x 44” was constructed from 2” x 2” boards screwed together 
to form a frame large enough to support several presses at one time. Presses were placed on 
top of the frame on their sides. The frame base and the exposed sides of the presses were 
wrapped in several layers of tightly woven cotton fabric that forced air to rise through the 
presses as it escaped the chamber. A Patton heater, model PUH682, was used as a heat 
source. The heater was set on the lower wattage setting (750w) and the thermostat was set at 
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approximately 25%. This resulted in heating cycles of 18-22 seconds separated by periods 
from 137-145 seconds in which the dryer was off. The air inside the chamber maintained an 
approximate temperature of 60° C (140° F). A specimen typically dried in 48-96 hours 
depending on the thickness of the specimen, the moisture in and on the plant at the time of 
collection, and environmental conditions during drying such as humidity and precipitation. 
Although specimens were collected during the rainy season, this technique dried specimens 
successfully without fungal or bacterial contamination. 
Terminology 
Much of the methodology and terminology for this study was based on Amiguet et al. 
2005 study. For example, a single record of use by a participant for one of the 50 plants is 
termed a “use-report.” The term “usage category” is used to group aliments into related 
systems. A participant may have many use-reports for a species but it may only be counted 
once for each usage category. Participants’ interviews were independent and data were 
compiled to form a single dataset. Twenty-two usage categories, all recognized by the 
Economic Botany Data Collection Standard (Cook, 1995), were used. The category “culture-
bound syndromes” (Weller et al. 2002) was included to classify folk illnesses that are not 
recognized as diseases by medical practitioners. There were twenty-three usage categories 
used: blood system disorders (BLO), circulatory system disorders (CIR), culture-bound 
syndromes (CUL), digestive system disorders (DIG), endocrine system disorders (END), 
genitourinary system disorders (GEN), Ill-defined syndromes (IDS), for example, dizziness, 
fainting, malaise/fatigue, and growing pains, immune system disorders (IMM), 
infections/infestations (INFE), inflammation (INFL), injuries (INJ), mental disorders (MEN), 
metabolic system disorders (MET), muscular-skeletal system disorders (MUS), neoplasms 
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(NEO), nervous system disorders (NER), nutritional disorders (NUT), pain (PAI), poisonings 
(POI), pregnancy/birth/puerpuerium disorders (PRE), respiratory system disorders (RES), 
sensory system disorders (SEN), and skin/subcutaneous cellular tissue disorders (SKI). 
Data Analyses 
The dataset generated from participant interviews was analyzed using Pearson’s Chi-
square tests to identify the parameters significantly associated with knowing a name and/or a 
use for the 47 medicinal plant specimens. Participant responses for specimen duplicates are 
not included in the analyses. The same test was used to compare both name and use to three 
demographic variables, which were 1) gender, 2) age, and 3) participant’s location of 
residence. Mixed-effects logistic regression examined the effect of demographic variables on 
the probability of knowing a name or use for the plants. Mixed-effects models were used to 
account for the pseudoreplication by treating the individual as a random effect. Akaike 
information criterion (AIC) was used to select a statistical model, based on different 
combinations of three variables, to identify which variables best described the variation in the 
data. The reports of use were then partitioned into twenty-three usage categories and a 
binomial test was conducted to investigate association between the participant knowing a use 
for the medicinal plant specimen and also knowing a name for the specimen in each usage 
category. Each category was then also independently analyzed for informant consensus.  
Consensus 
Consensus methods have been used successfully in several ethnobotanical studies to 
verify results and to identify, through universal uses by multiple users, plants with potentially 
important active compounds (Amiguet et al. 2005, Trotter and Logan 1986, Heinrick, 2000 
Johns et al. 1990, Phillips and Gentry 1993, Johns et al. 1994). Consensus analyses were 
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used in this study to determine the commonality of the uses of the 47 study plants among the 
30 study participants. The number of use reports (nur) compared to the number of species in 
each category of use (nraxa) was used to calculate the informants’ consensus factor (Fic) which 
is the degree of agreement among participants using the following formula as given in 







Name and Use 
Fifty specimens, including three duplicates, were studied one at a time by each of the 
30 participants (N=1500). All participants provided the same response for each of the three 
duplicates suggesting a reliability of responses. A total of 47 plants (N=1410), with no 
duplicates, was used in the analyses. There were four possible results (Table 1) for 
participant responses: 1) participant knows name and knows use (33.5%), 2) participant 
knows name but does not know use (5.9%), 3) participant does not know name but does 
know use (10.5%), and 4) participant does not know name or use (49.9%). The most frequent 
response was participants not knowing either a name or a use. The least frequent observation 
was participants knowing a name for the plant but not a use.  
Males knew a name for specimens more frequently than females (Table 1). Males 
also knew a use for the specimens more frequently than females. The difference in positive 
responses from participants from Cayo District and Orange Walk District was less than 1% 
for name and 2% for use. With the exception of a single outlier participant in the less than 25 
years of age group; there was no more than a 9% difference in the number of observed 
reports for name and a 9% difference for observations for use by the other three age groups. 
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Table 1. Number of participants, percentage of study group, and percentages of positive 
responses for knowing name and for knowing use by gender, age groups, and district. 
Groups N value Percent  Name Use 
Male 11 37% 46% 48% 
Female 19 63% 36% 42% 
Age <25 1 3% 55% 53% 
Age 25-49 7 23% 34% 47% 
Age 50-74 16 53% 43% 44% 
Age 75+ 6 20% 34% 38% 
Cayo District 15 50% 39% 43% 
Orange Walk District 15 50% 40% 45% 
   
A Pearson’s Chi-square test was used to address the association of a participant 
knowing a plant name with knowing a use (X2 = 621.9, df = 1, p < 0.001). Results of the test 
showed that name and use were not independent of each other. If a participant knew the plant 
name he/she could be expected to know a use. Males knew a name for the plant specimens 
46% of the time and knew a use 48% of the time. Females knew a name for the plant 
specimens 36% of the time and knew a use 42% of the time. Pearson’s Chi-square tests 
showed that gender was not independent of name (X2 = 12.896, df = 1, p < 0.001) or use (X2 
= 4.922, df = 1, p < 0.05)  
Pearson’s Chi-square tests also indicated that the age of the participant was not 
independent of knowing a name (X2 = 17.052, df = 3, p < 0.001). However, age was 
independent of knowing a use (X2 = 6.668, df = 3, p = 0.083). Pearson’s Chi-square tests was 
used to determine if the location of a participant’s residence was a factor in knowing a name 
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and use. District of residence was independent of knowing both a name (X2 = 0.074, df = 1, p 
=0.785) and for knowing a use (X2 = 0.564, df = 1, p =0.453).  
Model Selection 
 Akaike information criterion (AIC) was used to select a statistical model, based on 
different combinations of variables, to identify which variables best describe the variation in 
the data (Burnham and Anderson 2002). Models tested included combinations of gender, age, 
and district for each individual participant. Results showed that the model with only gender 
was the best model for knowing the name of a plant. For plant use, no model displayed a 
better fit than the null model. Models with only gender or only district and the null model 
(participant only) had similar AIC values indicating equal goodness of fit (Table 2). 
 
Table 2. AIC value for name and use in model selection. 
Model AIC (Name) AIC (Use) 
Age + Gender * District + (1/Participant) 
Gender + Age + District + (1/Participant) 
Gender + Age + (1/Participant) 
Gender + District + (1/Participant) 
Age + District + (1/Participant) 
Gender + (1/Participant) 
Age  + (1/Participant) 
District + (1/Participant) 




















*Best fit of model; **Models with equal goodness of fit. 
 
Use reports placement into categories 
Each participant was asked to report as many uses he/she knew for each plant species. 
Plant uses reported by participants were grouped by body systems. The body system groups 
used were those from the Economic Botany Data Collection Standard (Cook 1995). Using 
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this system required some interpretation by the interviewer. Reports of multiples uses from a 
participant could result in a single recorded entry. For example, a participant might report a 
plant could be used for pain in the foot, in the leg, and in the shoulder. Although the pain is 
in three different locations in the body, all three uses are in the pain category and the three 
uses would be recorded as a single use-report. However, when a plant species was reported to 
be helpful for pain caused by injury, infection, or poisoning, each ailment was considered 
independent because each affected different body systems and three use-reports were 
recorded. This methodology follows procedures used in Amiguet et al. (2005). 
A total of 771 unique use-reports were reported for the 47 plant specimens, which 
collectively represented 23 usage categories. Seventy-six (9.8%) reports did not fit in any of 
the recognized usage categories as they were folk illnesses not recognized as diseases by 
biomedical practitioners. These were grouped in a category called “culture-bound 
syndromes” following Weller et al. (2002). For example, this category includes susto, a 
condition resulting from emotional trauma usually afflicting children. 
Categories Totals  
The most frequent plant use reported was for infection, with 176 records. The 
remaining categories ranged from 95 reports for skin/subcutaneous cellular tissue disorders 




Table 3. Percentages of total use reports, frequency, and observations in which name was 
known for each usage categories by descending counts of use-reports. P-values show the 
probability of knowing the plant name for the usage category identified. 








Infections/infestations (INFE) 12.5 176 141 <0.0001 
Skin/subcutaneous cellular tissue 
Disorders (SKI) 
  6.7 95 78 <0.0001 
Cultural bound syndromes (CUL)  5.4 76 56 <0.0001 
Pain (PAI)  4.7 66 47 <0.001 
Genitourinary system disorders 
(GEN) 
 4.5 64 47 <0.001 
Digestive system disorders(DIG)  3.8 53 45 <0.0001 
Blood system disorders (BLO)  2.6 37 34 <0.001 
Inflammation (INFL)  2.6 37 28 <0.05 
Endocrine system disorders 
(END) 
 2.3 32 25 <0.05 
Pregnancy/birth/puerpuerium 
disorders (PRE) 
 1.8 25 16 *ns 
Nervous system disorders (NER)  1.1 15 14 <0.001 
Injuries (INJ)  1.0 14 8 ns 
Neoplasms (NEO)  1.0 14 12 <0.05 
Circulatory system disorders 
(CIR) 
 0.9 13  9 ns 
Respiratory system disorders 
(RES) 
 0.9 12 10 <0.05 
Mental disorders (MEN)  0.7 10 10 <0.05 
Muscular-skeletal  system 
disorders (MUS) 
0.6 8  6 ns 
Poisoning (POI) 0.4 6  4 ns 
Immune system disorders (IMM) 0.4 5  4 **nt 
Nutritional disorders (NUT) 0.4 5  5 nt 
Sensory system disorders (SEN) 0.3 4  3 nt 
Ill-defined syndromes (IDS) 0.1 2  1 nt 
Metabolic system disorders 
(MET) 
0.1 2  2 nt 
*ns = not significant; **nt = not testable 
 A binomial test indicated an association between the participant knowing a name for 
the plant species and also knowing a use for the species in the following categories: blood 
system disorders, culture-bound syndrome, digestive system disorders, endocrine system 
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disorders, genitourinary system disorders, infections, inflammations, mental disorders, 
neoplasms, nervous system disorders, pain, respiratory system disorders, and for 
skin/subcutaneous cellular tissue disorders (Table 3). Pregnancy/birth/puerpuerium, injuries, 
and circulatory system disorders categories did not exhibit an association between knowing a 
use and knowing a name. 
Sample size for muscular-skeletal disorders and poisoning categories were testable 
but require 100% positive responses to obtain a p-value <0.05. Neither category met this 
condition. Additionally, due to small sample sizes, below the cutoff point for significance 
testing, probability values for ill-defined syndromes, immune system disorders, nutritional 
disorders, metabolic system disorders, and sensory system disorders could not be calculated.  
Informant Consensus Factor  
Heinrich (2000) and Amiguet et al. (2005) used participant consensus factor values as 
a means of indicating which species are well known among healers. A high level of 
consensus suggests that these plants are part of a well-defined tradition and that they may be 
very effective in the treatment of disease (Amiguet et al. 2005). In the aforementioned 
studies, the authors suggested that species with a high consensus factor should be further 
investigated for pharmacological usefulness. Heinrich (2000) defined a consensus factor as 
high if the value was 0.60 or higher; Amiguet et al. (2005) used 0.65 or higher as a high 
value. The informant consensus factor (Fic) was calculated for each of the 23 usage categories 
resulting in six with values ≥0.65 (Table 4). These categories, in alphabetical order, are blood 
system disorders, culture-bound syndromes, infections, mental disorders, nervous system 
disorders, and skin/subcutaneous cellular tissue disorders. The number of taxa that the 
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participants used to treat ailments in each of the 23 usage categories ranged from 40 in the 
INFE category to a low of two in both IDS and MET (Table 4) categories. 
Table 4. Usage categories, number of use reports, number of taxa, and informant consensus 
factor (Fic) value for each of the 23 usage categories by descending Fic value. Categories with 
a Fic value ≥0.65 are considered a high level of consensus. 
Usage Category No. of Use-reports No. of Taxa Fic 
NER 15 4 0.79 
INFE 176 40 0.78 
MEN 10 3 0.78 
BLO 37 11 0.72 
SKI 95 31 0.68 
CUL 76 27 0.65 
PAI 66 28 0.58 
DIG 53 23 0.58 
END 32 14 0.58 
GEN 64 28 0.57 
NEO 14 7 0.54 
INFL 37 18 0.53 
CIR 13 7 0.50 
INJ 14 9 0.38 
MUS 8 6 0.29 
RES 12 9 0.27 
PRE 25 19 0.25 
NUT 5 4 0.25 
POI 6 5 0.20 
IMM 5 5 0.00 
SEN 4 4 0.00 
MET 2 2 0.00 
IDS 2 2 0.00 
 
Specimen Identification 
The 50 medicinal plant specimens were identified by the use of dichotomous keys, 
comparison to accessioned herbarium specimens at the University of Texas at Austin’s Plant 
Resource Center, and the aid of experts in the plant families at the Plant Resource Center. Of 
the 50 medicinal plant specimens shown to each of the study’s participants 47 were identified 
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to the family level (Table 5).  There were a total of 44 unique species identified. Three were 
intentional duplicates used as a participant response reliability check. The Catalogue of Life: 
2014 Annual Checklist (Roskov et al. 2014) was used as the taxonomic source for all names 
except Parmentiera millspaughiana for which The Global Biodiversity Information Facility 
was used. A lack of reproductive material hindered identification of three species to family 
and several other species identification could not be made below the family level. The 44 
identified species were distributed among 31 plant families. Seven of the 31 plant families 
included more than one species. These families listed by order of most frequent to least are 
Fabaceae (4), Solanaceae (4), Euphorbiaceae (3), Rutaceae (3), Asteraceae (2), Malvaceae 
(2), and Rubiaceae (2). The other 24 plant families are represented by one species in the 
study set.  
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Table 5. List of plants in the study set and identifications, when possible.  
Family Genus 
Menispermaceae Cissampelos tropaeolifolia DC. 
Specimen #2: NA NA 
Euphorbiaceae Cnidoscolus aconitifolius (Mill.) I.M. Johnst. 
Cactaceae Nopalea cochenillifera (L.) Salm-Dyck 
Burseraceae Bursera simaruba (L.) Sarg. 
Rutaceae Ruta chalepensis L. 
Fabaceae Bauhinia herrerae (Britton & Rose) Standl. & Steyerm. 
Polypodiaceae Phlebodium decumanum (Willd.) J. Sm. 
Bignoniaceae Parmentiera millspaughiana L. O. Williams 
Euphorbiaceae Ricinus communis L. 
Solanaceae Capsicum annuum L. 
Malvaceae Sida glabra Miller 
Rubiaceae Hamelia patens Jacq. 
Fabaceae Cassia grandis L. f. 
Urticaceae Cecropia peltata L. 
Solanaceae Solanum lycopersicum L. 
Xanthorrhoeaceae Aloe vera (L.) Burm. f. 
Fabaceae Mimosa pudica L. 
Phyllanthaceae Phyllanthus liebmannianus Müll. Arg. 
Solanaceae **Solanum torvum Sw. 
Meliaceae Cedrela odorata L. 
Lauraceae Persea americana Mill.  
Annonaceae Mosannona depressa (Baill.) Chatrou  
Lamiaceae Mentha sp. 
Verbenaceae **Stachytarpheta cayennensis (Rich.) Vahl 
Acanthaceae Blechum pyramidatum (Lam.) Urb. 
Amaranthaceae Alternanthera sp. 
Asteraceae *Sphagneticola trilobata (L.) Pruski 
Euphorbiaceae Euphorbia pulcherrima Willd. Ex Klotzsch 
Fabaceae Piscidia piscipula (L.) Sarg. 
Lygodiaceae Lygodium venustum Sw. 
Oxalidaceae Oxalis alpina Rose ex Knuth 
Rutaceae Zanthoxylum sp. 
Asteraceae *Parthenium hysterophorus L. 
Specimen #37: NA NA 
Rutaceae Murraya paniculata (L.) Jacq. 
Malvaceae Byttneria aculeata Jacq. 
Solanaceae Specimen #40: NA 
Apocynaceae **Tabernaemontana donnell-smithii J. N. Rose ex J. D. Smith 
Araceae Specimen #42: NA 
Nyctaginaceae Bougainvillea glabra Choisy 
Specimen #44: NA NA 
Sapindaceae Serjania lundellii T. B. Croat 
Rubiaceae Psychotria berteroana DC. 
Moraceae Brosimum sp. 
Myrtaceae Eugenia capuli (Schltdl. & Cham.) Hook. & Arn. 
Piperaceae Piper sp. 





The use-reports can be used to help identify plant species with higher relative 
medicinal importance. A high consensus factor indicates a well-defined tradition of 
medicinal plant use and could aid in guided selection of plant species for future 
phytochemical, bioactivity, and toxicological investigation. Twenty-six of the 31 plant 
families and ten species of plants identified in this study have been reported in prior studies 
as having medicinal use.  
Comparison of Study Plants with Previous Studies 
Although not focused on WCH issues, several other studies were identified that either 
addressed similar questions or were conducted in nearby geographical areas, and included 
identification of plant names and uses. These studies include Amiguet et al. (2005), Ankli et 
al. (1999), Bussman and Glenn (2010), Michel et al. (2007), Jenett-Siems et al. (1999), and 
Yasir et al. (2010). Plants identified in these studies were compared to the species identified 
here as important to WCH issues. Of the 31 plant families included in this study five were 
not reported in the previously listed studies. These five plant families are: Lygodiaceae, 
Phyllanthaceae, Sapindaceae, Apocynaceae, and Xanthorrhoeaceae. The remaining 26 plant 
families in this study were reported in at least one of the previous studies stated above. 
Three plant specimens that were identified only to genus were common to at least one 
of the previous studies. The three genera in common are Mentha (Lamiaceae), Brosimum 
(Moraceae), and Zanthoxylum (Rutaceae); all three were reported by Bussman and Glenn 
(2010). Their reported uses are as an aphrodisiac, as a contraceptive and for hemorrhage, and 
for abortion and an aphrodisiac respectively. Medicinal values, although not specified, have 
been reported for members of the genus Zanthoxylum in both Amiguet et al. (2005) and 
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Ankli et al. (2007). Zanthoxylum was cited by Calderón et al. (2006) as having cytotoxic 
properties and by Smith et al. (2000) for possessing antiplasmodial activity.  
Ten plant specimens, which were identified to species, have been reported in one or 
more of the studies listed. Citations and reported uses are discussed below. 
Annonaceae 
 Mosannona depressa has been reported by Ankli et al. (2007) to be used for 
urological disorders. This use was not reported by participants. Mosannona depressa was 
only reported as having medicinal use in the digestive system disorders, pain, and 
skin/subcutaneous cellular tissue disorders categories. None of these uses were reported in 
any of the other studies. 
Burseraceae 
Bursera simaruba has been reported to be effective for both pain and infection by 
Amiguet et al. (2005) and Ankli et al. (2007); participants in this study reported the same 
uses. The infections category had a high degree of consensus (78%) among participants. In 
this study, Bursera simaruba was observed to be used for culture-bound syndromes, 
respiratory disorders, and for skin/subcutaneous cellular tissue disorders but these uses were 
not reported in the other studies. 
Fabaceae 
 Bauhinia herrerae was reported useful for treatment of gastrointestinal disorders by 
Ankli et al. (2007). No use-reports for this species fell into the digestive system disorders 
category. This species was reported to be effective for culture-bound syndromes, endocrine 
system disorders, genitourinary system disorders, infections, and pain categories. 
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 Mimosa pudica was reported as being useful to treat insomnia by Michel et al. 
(2007). In the current study, usage reports for this species included mental disorders, which 
was a category with a 78% agreement among participants. According to the Economic 
Botany Data Collection Standard (Cook 1995), insomnia is classified within mental 
disorders. Other use-reports for this species included blood system disorders, culture-bound 
syndromes, genitourinary system disorders, infections, neoplasms, nervous system disorders, 
pain, respiratory system disorders, and skin/subcutaneous cellular tissue disorders categories.  
Piscidia piscipula was reported by Ankli et al. (2007) as being used for 
gastrointestinal and respiratory system disorders. There were no use-reports for this species 
in the digestive system disorders category, but participants reported uses for respiratory 
system disorders. In addition, this species was reported as useful for treating culture-bound 
syndromes, genitourinary system disorders, infections, pain, pregnancy/birth/puerpuerium 
disorders, and skin/subcutaneous cellular tissue disorders. Five use-reports for this species 
reported use for infections. The other categories had one use-report each. 
Lauraceae 
 Persea americana was reported by Bussman and Glenn (2010) as a contraceptive. 
This study did not observe pregnancy/puerpuerium disorder use-reports for Persea 
americana. Yasir et al. (2010) reported P. americana useful as an anticonvulsant, an 
antiviral, to heal wounds and ulcers, an antioxidant, a hypoglycemic, and for weight loss. 
Participants reported similar uses for the muscular-skeletal system disorders, infections, 
digestive system disorders, and mental disorders categories. Both infections and mental 
disorders categories had a high consensus value among participants. Use-reports were also 
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observed in the genitourinary system disorders, inflammation, metabolic system disorders, 
pain, and respiratory system disorders categories.  
Menispermaceae 
 Cissampelos tropaeolifolia has been reported to be used to release the placenta by 
both Amiguet et al. (2005) and by Michel et al. (2007). One participant (<6%) reported a 
single use in the pregnancy/puerpuerium disorders category. This species was also reported 
for culture-bound syndromes, digestive system disorders, endocrine system disorders, 
genitourinary system disorders, infections, inflammation, and sensory system disorders. 
Rubiaceae 
 Hamelia patens has been reported by Ankli et al. (2007) as being useful for 
dermatological conditions and by Janett-Siems et al. (1999) as an antiplasmodial. 
Participants reported usages for H. patens in the treatment of disorders in skin/subcutaneous 
cellular tissues, circulatory system, digestive system, endocrine system, genitourinary 
system, infections, inflammation, injuries, muscular-skeletal system, and pain categories. The 
skin/subcutaneous cellular tissue disorders category also showed a high degree of consensus 
with 68% of participants in agreement. 
Rutaceae 
 Murraya paniculata was reported by Ankli et al. (2007) to be used for respiratory 
system disorders. One participant reported a single use in the respiratory system disorders 
usage category. Other uses reported were the culture-bound syndromes, infections, nervous 
system disorders, pain, and skin/subcutaneous cellular tissue disorders categories. 
Ruta chalepensis was reported by Ankli et al. (2007) to be used to treat pain and 
infections. Usage categories reported by participants for this species included pain, 
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infections, digestive system disorders, inflammations, nutritional disorders, and sensory 
system disorders. The infection category had a high consensus among participants. 
Five species, Bursera simaruba, Mimosa pudica, Persea americana, Hamelia patens, 
and Ruta chalepensis, were reported by participants to be useful for categories with a high 
degree of informant consensus (≥65%) and had previously been reported to have similar uses 
by relevant studies. Cnidoscolus aconitifolius was not mentioned in the other studies; 





Based on the findings of this study, a participant who knew the name of a species 
typically also knew the use of the species. However, in half of the observations participants 
did not know the name or use for a species. These results indicate that knowledge about the 
plants included in the plant set is limited. Only rarely did a participant know only a name or 
only a use. The age of a participant was associated with knowing a name for a species but not 
for a use. The district of residence for a participant was not important in knowing either a 
name or a use. The gender of the participant was important in knowing both a name and a 
use. In addition, gender of the participant provided the best model for knowing a name. 
Models with only gender or district were equal to the null model for use. 
Commonality helps validate traditional uses.  For example, in this study six usage 
categories (INFE, NER, SKI, BLO, CUL, MEN) out of 23 had high consensus values. Of 
these, three high consensus categories (INFE, NER, & SKI) contained four species that had 
been reported to have similar uses in other studies. Heinrich (2000) and Amiguet et al. 
(2005) used participant consensus factor values as a means of indicating which species are 
well known among healers, which suggests that these plants are may be very effective in the 
treatment of disease (Amiguet et al. 2005). In the aforementioned studies, the authors 
suggested that species with a high consensus factor should be further investigated for 
pharmacological usefulness. In addition, novelty of use can help identify alternative species 
and uses. For example, Cnidoscolus aconitifolius was used by 70% of the participants to treat 
blood system disorders and was not reported in any of the other studies. 
In addition to the questions addressed in this paper, the dataset can be used to ask 
many more questions. For example: is there a difference in plant recognition depending on 
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whether the species was contributed by participants or by the project plant expert? Would 
participants who share demographic attributes with the study’s plant expert (male, 75 years 
or older, and Cayo District resident) have greater recognition of the plant species? The 
personal interviews provided many more demographic variables that may be investigated, for 
example: how does level of education, number of years practicing traditional medicine, or 
number of generations living in a home influence the recognition and knowledge of use?  
Ethnicity, occupation, and religion may be important variables. Finally, inclusion of more 
participants in the <25 age category would provide a better insight into that cohort.  
Belize has four additional districts (Corozal District, Belize District, Toledo District, 
and the Stann Creek District) that were not included in this study. Will the findings of this 
study persist throughout the rest of the country? What are the active chemical compounds 
present in the plants identified here and how are these compounds related to those presently 
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